Vascular endothelial growth factor (VEGF) is a crucial regulator of angiogenesis that stimulates proliferation of endothelial cells and increases vascular permeability. Placenta growth factor (PlGF) is a member of the VEGF family that binds to VEGF receptor 1 (VEGFR-1) and can heterodimerize with VEGF. Its role in angiogenesis, however, is the subject of some debate. Teresa Odorisio and co-workers have examined the function of PlGF by generating transgenic mice that overexpress PlGF in the skin (seep. 2559). They find that the mice exhibit increases in the number, size and branching of blood vessels, as well as enhanced vascular permeability, which indicates that PlGF has a potent angiogenic effect. (The levels of homodimeric VEGF are reduced in keratinocytes from the transgenic mice probably owing to formation of VEGF-PlGF heterodimers.) Moreover, in contrast to mice overexpressing VEGF,mice overexpressing PlGF have strongly increased vessel sizes and hypervascularization persisting in adult life. The authors therefore conclude that the biological effects of PlGF are different from those of VEGF and do not simply reflect its postulated role as a decoy for its relative.
Angiogenic effects of placenta growth factor
Angiogenic effects of placenta growth factor. J Cell Sci 15 June 2002; 115 (12): e1205. doi:
Download citation file:
Advertisement
Cited by
Call for papers: Cell Biology of Mitochondria
We are welcoming submissions for our upcoming special issue: Cell Biology of Mitochondria. This issue will be coordinated by two Guest Editors: Ana J. Garcia-Saez (University of Cologne, Germany) and Heidi McBride (McGill University, Canada). Submission deadline: 1 October 2024.
Focal adhesion kinase signalling – tumour vulnerabilities and clinical opportunities
In this Review, David Schlaepfer and colleagues summarise 30 years of focal adhesion kinase (FAK) research with a view of the ongoing clinical testing of small-molecule FAK inhibitors. The authors touch on how FAK plays an important signal integration role and ultimately functions to guide cellular behaviour. Additionally, the authors discuss how FAK inhibition might present a powerful tool to influence the physiological response to other therapeutic approaches.
JCS-FocalPlane Training Grants
Early-career researchers - working in an area covered by JCS - who would like to attend a microscopy training course, please apply. Deadline dates for 2024 applications: 7 September (decision by week commencing 8 October 2024); 22 November (decision by week commencing 16 December).
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Interview with Journal of Cell Science Editor Rob Parton
Read our interview with Rob Parton, a Cell Scientist to Watch, about his career journey leading him from the UK to the University of Queensland in Brisbane, Australia, the evolution of the membrane trafficking field and his advice for running a highly collaborative lab. As a Journal of Cell Science Editor, Rob brings to the journal his expertise in multiscale analysis of membrane function, membrane microdomains, lipid droplets and advanced microscopy techniques in cell biology.